{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:26:18Z","timestamp":1793964378631,"version":"4.8.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Research Program from Research Department of Khon Kaen University and the National Research Council of Thailand through the Hub of Knowledge Grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-14451-9","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T08:12:41Z","timestamp":1754727161000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Serum peptide biomarkers by MALDI-TOF MS coupled with machine learning for diagnosis and classification of hepato-pancreato-biliary cancers"],"prefix":"10.1038","volume":"15","author":[{"given":"Piya","family":"Prajumwongs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attapol","family":"Titapun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasin","family":"Thanasukarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apiwat","family":"Jareanrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natcha","family":"Khuntikeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krit","family":"Rattanarak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisana","family":"Namwat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poramate","family":"Klanrit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arporn","family":"Wangwiwatsin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarin","family":"Chindaprasirt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supinda","family":"Koonmee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakasit","family":"Sa-Ngiamwibool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nattha","family":"Muangritdech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawanya","family":"Charoenlappanit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janthima","family":"Jaresitthikunchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sittiruk","family":"Roytrakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Watcharin","family":"Loilome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,9]]},"reference":[{"key":"14451_CR1","unstructured":"Akhoundova, D., Fritsch, R. M. & Hussung, S. J. h. T. O. H. Precision oncology for hepato-pancreato-biliary (HPB) cancers state of the art and future directions. 5, 52\u201359 (2020)."},{"key":"14451_CR2","doi-asserted-by":"publisher","first-page":"833","DOI":"10.21037\/jgo-22-1067","volume":"14","author":"DM Kerekes","year":"2023","unstructured":"Kerekes, D. M. et al. Hepatopancreatobiliary malignancies: time to treatment matters. J. Gastrointest. Oncol. 14, 833\u2013848. https:\/\/doi.org\/10.21037\/jgo-22-1067 (2023).","journal-title":"J. Gastrointest. Oncol."},{"key":"14451_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.dld.2024.06.021","volume":"57","author":"M Maspero","year":"2025","unstructured":"Maspero, M., Sposito, C., Mazzaferro, V., Ercolani, G. & Cucchetti, A. Cure after surgery for hepato-pancreato-biliary cancers: A systematic review. Dig. Liver Disease. 57, 1\u20137. https:\/\/doi.org\/10.1016\/j.dld.2024.06.021 (2025).","journal-title":"Dig. Liver Disease"},{"key":"14451_CR4","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.hpb.2016.05.016","volume":"18","author":"GA Margonis","year":"2016","unstructured":"Margonis, G. A. et al. Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic biliary malignancy consortium. HPB (Oxford). 18, 872\u2013878. https:\/\/doi.org\/10.1016\/j.hpb.2016.05.016 (2016).","journal-title":"HPB (Oxford)"},{"key":"14451_CR5","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1016\/j.hpb.2022.04.007","volume":"24","author":"YJ Xiang","year":"2022","unstructured":"Xiang, Y. J. et al. Recurrence hazard rate in patients with hepatocellular carcinoma and bile duct tumor thrombus: a multicenter observational study. HPB 24, 1703\u20131710. https:\/\/doi.org\/10.1016\/j.hpb.2022.04.007 (2022).","journal-title":"HPB"},{"key":"14451_CR6","doi-asserted-by":"publisher","unstructured":"Evans, D., Hajibandeh, S., Hajibandeh, S. & Athwal, T. HPB SO43 - Meta-analysis of completion pancreatectomy for local recurrence of pancreatic cancer after the index pancreatectomy. Br. J. Surg. 111 https:\/\/doi.org\/10.1093\/bjs\/znae271.275 (2024).","DOI":"10.1093\/bjs\/znae271.275"},{"key":"14451_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.diii.2023.11.002","volume":"105","author":"A Jajodia","year":"2024","unstructured":"Jajodia, A., Soyer, P., Barat, M. & Patlas, M. N. Imaging of hepato-pancreato-biliary emergencies in patients with cancer. Diagn. Interv. Imaging. 105, 47\u201356. https:\/\/doi.org\/10.1016\/j.diii.2023.11.002 (2024).","journal-title":"Diagn. Interv. Imaging"},{"key":"14451_CR8","doi-asserted-by":"publisher","unstructured":"Elbanna, K. Y. & Kielar, A. Z. Computed tomography versus magnetic resonance imaging for hepatic lesion characterization\/diagnosis. 17, 159\u2013164  https:\/\/doi.org\/10.1002\/cld.1089 (2021).","DOI":"10.1002\/cld.1089"},{"key":"14451_CR9","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1007\/s00261-017-1167-7","volume":"42","author":"CH Wu","year":"2017","unstructured":"Wu, C. H. et al. Comparative radiological pathological study of biliary intraductal tubulopapillary neoplasm and biliary intraductal papillary mucinous neoplasm. Abdom. Radiol. (NY). 42, 2460\u20132469. https:\/\/doi.org\/10.1007\/s00261-017-1167-7 (2017).","journal-title":"Abdom. Radiol. (NY)"},{"key":"14451_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s12328-019-01040-3","volume":"13","author":"M Fujii","year":"2020","unstructured":"Fujii, M., Okamoto, Y. & Shiode, J. A case of cystic intraductal papillary neoplasm of the bile duct with associated adenocarcinoma. Clin. J. Gastroenterol. 13, 219\u2013224. https:\/\/doi.org\/10.1007\/s12328-019-01040-3 (2020).","journal-title":"Clin. J. Gastroenterol."},{"key":"14451_CR11","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1007\/s11605-016-3103-5","volume":"20","author":"WJ Kim","year":"2016","unstructured":"Kim, W. J. et al. Clinicopathological features and Long-Term outcomes of intraductal papillary neoplasms of the intrahepatic bile duct. J. Gastrointest. Surg. 20, 1368\u20131375. https:\/\/doi.org\/10.1007\/s11605-016-3103-5 (2016).","journal-title":"J. Gastrointest. Surg."},{"key":"14451_CR12","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1007\/s11605-019-04235-8","volume":"24","author":"Y You","year":"2020","unstructured":"You, Y. et al. Recurrence after resection for intraductal papillary neoplasm of bile duct (IPNB) according to tumor location. J. Gastrointest. Surg. 24, 804\u2013812. https:\/\/doi.org\/10.1007\/s11605-019-04235-8 (2020).","journal-title":"J. Gastrointest. Surg."},{"key":"14451_CR13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3748\/wjg.v28.i2.216","volume":"28","author":"H Hanif","year":"2022","unstructured":"Hanif, H. et al. Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma. World J. Gastroenterol. 28, 216\u2013229. https:\/\/doi.org\/10.3748\/wjg.v28.i2.216 (2022).","journal-title":"World J. Gastroenterol."},{"key":"14451_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","volume":"6","author":"H Zhao","year":"2021","unstructured":"Zhao, H. et al. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal. Transduct. Target. Ther. 6, 263. https:\/\/doi.org\/10.1038\/s41392-021-00658-5 (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"14451_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.enz.2017.08.001","volume":"42","author":"J Fan","year":"2017","unstructured":"Fan, J., Ning, B., Lyon, C. J. & Hu, T. Y. Circulating peptidome and Tumor-Resident proteolysis. Enzymes 42, 1\u201325. https:\/\/doi.org\/10.1016\/bs.enz.2017.08.001 (2017).","journal-title":"Enzymes"},{"key":"14451_CR16","doi-asserted-by":"publisher","first-page":"0019","DOI":"10.34133\/bmef.0019","volume":"4","author":"L Li","year":"2023","unstructured":"Li, L., Wu, J., Lyon, C. J., Jiang, L. & Hu, T. Y. Clinical peptidomics: advances in instrumentation, analyses, and applications. BME Front. 4, 0019. https:\/\/doi.org\/10.34133\/bmef.0019 (2023).","journal-title":"BME Front."},{"key":"14451_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13195-017-0318-y","volume":"9","author":"S Ostrowitzki","year":"2017","unstructured":"Ostrowitzki, S. et al. A phase III randomized trial of gantenerumab in prodromal alzheimer\u2019s disease. Alzheimers Res. Ther. 9, 95. https:\/\/doi.org\/10.1186\/s13195-017-0318-y (2017).","journal-title":"Alzheimers Res. Ther."},{"key":"14451_CR18","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41569-020-0381-0","volume":"17","author":"JP Goetze","year":"2020","unstructured":"Goetze, J. P. et al. Cardiac natriuretic peptides. Nat. Reviews Cardiol. 17, 698\u2013717. https:\/\/doi.org\/10.1038\/s41569-020-0381-0 (2020).","journal-title":"Nat. Reviews Cardiol."},{"key":"14451_CR19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41586-018-0810-y","volume":"565","author":"N Hilf","year":"2019","unstructured":"Hilf, N. et al. Actively personalized vaccination trial for newly diagnosed glioblastoma. Nature 565, 240\u2013245. https:\/\/doi.org\/10.1038\/s41586-018-0810-y (2019).","journal-title":"Nature"},{"key":"14451_CR20","doi-asserted-by":"publisher","unstructured":"Sandanayake, N. S. et al. Identification of potential serum peptide biomarkers of biliary tract cancer using MALDI MS profiling. BMC Clin. Pathol. 14 https:\/\/doi.org\/10.1186\/1472-6890-14-7 (2014).","DOI":"10.1186\/1472-6890-14-7"},{"key":"14451_CR21","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1039\/c8an02241k","volume":"144","author":"HG Park","year":"2019","unstructured":"Park, H. G. et al. MALDI-TOF MS-based total serum protein fingerprinting for liver cancer diagnosis. Analyst 144, 2231\u20132238. https:\/\/doi.org\/10.1039\/c8an02241k (2019).","journal-title":"Analyst"},{"key":"14451_CR22","doi-asserted-by":"publisher","first-page":"8991","DOI":"10.1038\/s41598-023-36159-4","volume":"13","author":"SS Kim","year":"2023","unstructured":"Kim, S. S. et al. Quantifiable peptide library bridges the gap for proteomics based biomarker discovery and validation on breast cancer. Sci. Rep. 13, 8991. https:\/\/doi.org\/10.1038\/s41598-023-36159-4 (2023).","journal-title":"Sci. Rep."},{"key":"14451_CR23","doi-asserted-by":"publisher","unstructured":"Rungkamoltip, P., Roytrakul, S. & Navakanitworakul, R. MALDI-TOF MS analysis of serum peptidome patterns in cervical cancer. Biomedicines 11 https:\/\/doi.org\/10.3390\/biomedicines11082327 (2023).","DOI":"10.3390\/biomedicines11082327"},{"key":"14451_CR24","doi-asserted-by":"publisher","first-page":"121331","DOI":"10.1016\/j.talanta.2020.121331","volume":"220","author":"J Sun","year":"2020","unstructured":"Sun, J. et al. Evaluation of prostate cancer based on MALDI-TOF MS fingerprinting of nanoparticle-treated serum proteins\/peptides. Talanta 220, 121331. https:\/\/doi.org\/10.1016\/j.talanta.2020.121331 (2020).","journal-title":"Talanta"},{"key":"14451_CR25","doi-asserted-by":"publisher","first-page":"21641","DOI":"10.1038\/s41598-022-26132-y","volume":"12","author":"S Ploypetch","year":"2022","unstructured":"Ploypetch, S. et al. Utilizing MALDI-TOF MS and LC-MS\/MS to access serum peptidome-based biomarkers in canine oral tumors. Sci. Rep. 12, 21641. https:\/\/doi.org\/10.1038\/s41598-022-26132-y (2022).","journal-title":"Sci. Rep."},{"key":"14451_CR26","doi-asserted-by":"publisher","first-page":"19136","DOI":"10.1038\/s41598-020-76195-y","volume":"10","author":"JW Lee","year":"2020","unstructured":"Lee, J. W. et al. Potential of MALDI-TOF-based serum N-glycan analysis for the diagnosis and surveillance of breast cancer. Sci. Rep. 10, 19136. https:\/\/doi.org\/10.1038\/s41598-020-76195-y (2020).","journal-title":"Sci. Rep."},{"key":"14451_CR27","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1007\/s00595-013-0752-9","volume":"44","author":"M Kanda","year":"2014","unstructured":"Kanda, M. et al. The combination of the serum carbohydrate antigen 19\u2009\u2013\u20099 and carcinoembryonic antigen is a simple and accurate predictor of mortality in pancreatic cancer patients. Surg. Today. 44, 1692\u20131701. https:\/\/doi.org\/10.1007\/s00595-013-0752-9 (2014).","journal-title":"Surg. Today"},{"key":"14451_CR28","doi-asserted-by":"publisher","unstructured":"Antonarakis, E. S. et al. The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up. 109, 32\u201339 https:\/\/doi.org\/10.1111\/j.1464-410X.2011.10422.x (2012).","DOI":"10.1111\/j.1464-410X.2011.10422.x"},{"key":"14451_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12864-019-6413-7","volume":"21","author":"D Chicco","year":"2020","unstructured":"Chicco, D. & Jurman, G. The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation. BMC Genom. 21, 6. https:\/\/doi.org\/10.1186\/s12864-019-6413-7 (2020).","journal-title":"BMC Genom."},{"key":"14451_CR30","doi-asserted-by":"publisher","first-page":"104034","DOI":"10.1016\/j.engappai.2020.104034","volume":"97","author":"X Gao","year":"2021","unstructured":"Gao, X. et al. A multiclass classification using one-versus-all approach with the differential partition sampling ensemble. Eng. Appl. Artif. Intell. 97, 104034. https:\/\/doi.org\/10.1016\/j.engappai.2020.104034 (2021).","journal-title":"Eng. Appl. Artif. Intell."},{"key":"14451_CR31","doi-asserted-by":"crossref","unstructured":"Krebs, R., Bagui, S. S., Mink, D. & Bagui, S. C. Applying Multi-CLASS support vector machines: One-vs.-One vs. One-vs.-All on the UWF-ZeekDataFall22 dataset. 13, 3916 (2024).","DOI":"10.3390\/electronics13193916"},{"key":"14451_CR32","doi-asserted-by":"publisher","first-page":"e0293607","DOI":"10.1371\/journal.pone.0293607","volume":"19","author":"Y Yang","year":"2024","unstructured":"Yang, Y. & Mirzaei, G. Performance analysis of data resampling on class imbalance and classification techniques on multi-omics data for cancer classification. PLoS One. 19, e0293607. https:\/\/doi.org\/10.1371\/journal.pone.0293607 (2024).","journal-title":"PLoS One"},{"key":"14451_CR33","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00784-014-1293-3","volume":"19","author":"P Chaiyarit","year":"2015","unstructured":"Chaiyarit, P., Taweechaisupapong, S., Jaresitthikunchai, J., Phaonakrop, N. & Roytrakul, S. Comparative evaluation of 5-15-kDa salivary proteins from patients with different oral diseases by MALDI-TOF\/TOF mass spectrometry. Clin. Oral Investig. 19, 729\u2013737. https:\/\/doi.org\/10.1007\/s00784-014-1293-3 (2015).","journal-title":"Clin. Oral Investig"},{"key":"14451_CR34","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3892\/br.2018.1042","volume":"8","author":"T Yigitbasi","year":"2018","unstructured":"Yigitbasi, T. et al. An efficient biomarker panel for diagnosis of breast cancer using surface-enhanced laser desorption ionization time-of-flight mass spectrometry. Biomed. Rep. 8, 269\u2013274. https:\/\/doi.org\/10.3892\/br.2018.1042 (2018).","journal-title":"Biomed. Rep."},{"key":"14451_CR35","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1038\/s41598-025-87124-2","volume":"15","author":"V Thanasukarn","year":"2025","unstructured":"Thanasukarn, V. et al. Discovery of novel serum peptide biomarkers for cholangiocarcinoma recurrence through MALDI-TOF MS and LC-MS\/MS peptidome analysis. Sci. Rep. 15, 2582. https:\/\/doi.org\/10.1038\/s41598-025-87124-2 (2025).","journal-title":"Sci. Rep."},{"key":"14451_CR36","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1186\/s12885-017-3467-2","volume":"17","author":"A Swiatly","year":"2017","unstructured":"Swiatly, A. et al. MALDI-TOF-MS analysis in discovery and identification of serum proteomic patterns of ovarian cancer. BMC Cancer. 17, 472. https:\/\/doi.org\/10.1186\/s12885-017-3467-2 (2017).","journal-title":"BMC Cancer"},{"key":"14451_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10147-011-0259-6","volume":"17","author":"S Wu","year":"2012","unstructured":"Wu, S. et al. Identification of serum biomarkers for ovarian cancer using MALDI-TOF-MS combined with magnetic beads. Int. J. Clin. Oncol. 17, 89\u201395. https:\/\/doi.org\/10.1007\/s10147-011-0259-6 (2012).","journal-title":"Int. J. Clin. Oncol."},{"key":"14451_CR38","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.3390\/app12063030","volume":"12","author":"R Pais","year":"2022","unstructured":"Pais, R., Grigaite, R., Lacey, J., Jardine, C. & Iles, R. A. Rapid and affordable screening tool for Early-Stage ovarian cancer detection based on MALDI-ToF MS of blood serum. Appl. Sci. 12, 3030. https:\/\/doi.org\/10.3390\/app12063030 (2022).","journal-title":"Appl. Sci."},{"key":"14451_CR39","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/BF00994018","volume":"20","author":"C Cortes","year":"1995","unstructured":"Cortes, C. & Vapnik, V. Support-vector networks. Mach. Learn. 20, 273\u2013297. https:\/\/doi.org\/10.1007\/BF00994018 (1995).","journal-title":"Mach. Learn."},{"key":"14451_CR40","doi-asserted-by":"publisher","first-page":"W398","DOI":"10.1093\/nar\/gkae253","volume":"52","author":"Z Pang","year":"2024","unstructured":"Pang, Z. et al. MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation. Nucleic Acids Res. 52, W398\u2013w406. https:\/\/doi.org\/10.1093\/nar\/gkae253 (2024).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14451-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14451-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14451-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T20:02:06Z","timestamp":1755115326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14451-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,9]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14451"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-14451-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,9]]},"assertion":[{"value":"6 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29169"}}